Glow Takes Receipt of MyCell® Reactor for Prototyping and Formulation for Canadian Processing; Receives CSA Standards Approval
News
Glow Lifetech Strengthens Management Team with Manufacturing and Product Development Leaders; Provides Management Overview
Glow LifeTech Announces Upgrade to OTCQB Under Ticker ‘GLWLF’
Glow Acquires Strategic Equity Investment in Nova Mentis
Glow LifeTech Secures Canadian Processing Facility; Begins Build-out to Produce Next-Generation Cannabis Ingredients
Glow LifeTech Reports on Additional Research Results on ArtemiC™ and Positive Implications for COVID-19 Variants
Glow LifeTech Announces Successful First Commercial Production of ArtemiC™ for Global Distributor and a Second Production Scaled to Meet Growing Global Demand
Glow LifeTech Submits Application to Health Canada for Natural Health Product Following Successful COVID-19 Phase II Clinical Trial